- Types of Eczema
- Eczema in Children
- Living Well
- Eczema Products
- Get Involved
- For Medical Professionals
In September 2017, NEA launched its advocacy program, Raise Your Voice! We asked members of our community to email their elected officials to let them know that eczema is an important public health issue. We also asked people who participated in this campaign to request that their representatives sponsor a resolution declaring October, Eczema Awareness Month. Our campaign met with resounding success.
Grassroots advocates in Georgia, Tennessee, Illinois, Pennsylvania, Michigan, Louisiana, and Oklahoma met with their elected representatives and successfully pushed through an Eczema Awareness Month resolution. We are convinced that we can get resolutions passed in at least seven states in 2019, but we need your help.
Would you be willing to help make October Eczema Awareness Month in your state? In most states, the process is very strait forward. And, NEA’s automated, online advocacy system makes identifying and e-mailing your elected representatives very simple.
Have you ever been prescribed a medication by your doctor just to be told by your insurer that you have to take another medication first? If you have, then you’ve experienced step therapy.
Step therapy is a protocol that insurers use to steer patients away from the medications prescribed by their doctors and toward cheaper medications. Essentially, insurers deny coverage for patients’ prescribed medications unless the patients try cheaper drugs for a period of time first. This protocol has the effect of discouraging patients from trying to get the medicines they need to manage their conditions.
The National Eczema Association believes that this practice is wrong and is working with coalitions in several states and at the federal level of government to pass legislation which requires insurers step therapy protocols to be rational and in keeping with standards of good medical practice. Currently, NEA supports the following step therapy bills:
Updated May 16, 2019
Federal – HR 2279 (Ruiz & Wenstrup)
A bipartisan bill that would require employer health insurance plans that are organized under federal law to exempt patients from step therapy requirements under certain conditions. It would vastly improve access to treatment and medication for the 114 million Americans who are insured by one of these plans.
Oregon – HB 2668 (Malstrom)
Comprehensive bill that would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions. It would also require insurers to implement web-based application procedures for prior authorization applications and impose minimum response times on insurers.
If you live in Oregon, please click the “Take Action” button to tell your legislators that you support step therapy reform.
These are concurrent bills that would require insurers’ step therapy protocols to be consistent with the standards of good medical practice and that the insurers provide exceptions from step therapy protocols under certain conditions, such as when a patient is likely to adverse reaction to a step medication or when the medication is not likely to work given the patient’s medical history.
If you live in Massachusetts, please click the “Take Action” button to tell your elected representatives that you support step therapy reform.